肝癌在一般癌癥中發(fā)病率很高，是全世界最常見(jiàn)的死亡原因之一。基于這些事實(shí)，《肝癌》雜志越來(lái)越需要更好地了解這種惡性腫瘤的病因、機(jī)制和治療。它為國(guó)際研究人員和臨床醫(yī)生提供了一個(gè)研究成果的平臺(tái)，側(cè)重于該病的分子癌變、預(yù)防、監(jiān)測(cè)、診斷和治療，包括分子靶向治療。肝癌以原創(chuàng)性和綜述性文章的形式在人類(lèi)和實(shí)驗(yàn)?zāi)Ｐ椭邪l(fā)表與肝癌領(lǐng)域相關(guān)的臨床和轉(zhuǎn)化研究。

Liver cancer has a very high prevalence among cancers in general and is one of the most common causes of death worldwide. Based on these facts, the journal Liver Cancer serves the growing need to better understand the causes, mechanisms and therapy of the malignancy. It provides the international community of researchers and clinicians with a platform for their research results, focusing on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy, of the disease. Liver Cancer publishes clinical and translational research related to the field of liver cancer in both humans and experimental models in the form of original and review articles.